ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Losartan Benefits Are Mediated Through SIRT1 Activation in Rat Reduced Size Orthotopic Liver Transplantation

E. Pantazi,1 M. Bejaoui,1 M. Zaouali,1 E. Folch-Puy,1 A. Rolo,2,3 A. Panisello,1 C. Palmeira,2 J. Rosello-Catafau.1

1Experimental Pathology, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Barcelona, Spain
2Department of Life Sciences, Faculty of Science and Technology, University of Coimbra, Coimbra, Portugal
3Center for Neurosciences and Cell Biology, Department of Zoology, University of Coimbra, Coimbra, Portugal.

Meeting: 2015 American Transplant Congress

Abstract number: A18

Keywords: Apoptosis, Ischemia, Liver grafts, Preservation solutions

Session Information

Session Name: Poster Session A: Acute Allograft Rejection

Session Type: Poster Session

Date: Saturday, May 2, 2015

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Background: Silent Information Regulator 1 (SIRT1) is a histone deacetylase that has been associated with protective mechanisms against IRI, but its role in liver transplantation has been poorly investigated. The purpose of this study is to evaluate the possible SIRT1 implication in reduced orthotopic liver transplantation (ROLT) in the rat, as well as to examine a potential relationship between SIRT1 and Losartan, an antagonist of angiotensin II type I receptor (AT1R) antagonist. Methods: Livers of male Sprague-Dawley rats were preserved in University of Wisconsin (UW) storage solution for 1 hour at 4 C and then subjected to ROLT. In an additional group, Losartan was orally administered (5 mg/kg) 24 hours and 1 hour before the surgical procedure to both the donor and the recipient rats respectively. Liver injury (transaminases), SIRT1 protein levels and activity, SIRT3 protein and mRNA expression, endoplasmic reticulum stress (ERS) parameters (GRP78, IRE1a and p-eIf2), heat shock proteins (HO-1, HSP70) expression and apoptosis parameters (Caspase 12 and 3) were measured 24 hours after reperfusion. Results: Here, we demonstrated that Losartan pretreatment diminished hepatic injury in ROLT, which was consistent with induction of both SIRT1 protein expression and activity. Losartan administration provoked also enhanced NAD+ levels, the co-factor necessary for SIRT1 activity. Furthermore, SIRT1 induction by Losartan pre-treatment coincided with decreases in the ERS parameters and in liver apoptosis. Losartan pretreatment also modulated heat shock proteins expression. In addition, both mRNA and protein levels of SIRT3 were comparable in ROLT and Losartan + ROLT group. Conclusions: We evidenced that SIRT1 is induced upon Losartan pretreatment in ROLT and can be considered as an emerging therapeutic strategy in order to diminish hepatic IRI associated to ROLT.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Pantazi E, Bejaoui M, Zaouali M, Folch-Puy E, Rolo A, Panisello A, Palmeira C, Rosello-Catafau J. Losartan Benefits Are Mediated Through SIRT1 Activation in Rat Reduced Size Orthotopic Liver Transplantation [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/losartan-benefits-are-mediated-through-sirt1-activation-in-rat-reduced-size-orthotopic-liver-transplantation/. Accessed June 1, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences